Pharmscript, L.L.C. Sustainability Profile
Pharmscript, L.L.C., headquartered in the United States, is a leading provider of pharmacy services tailored for long-term care facilities. Founded in 2015, the company has rapidly expanded its operations across multiple states, establishing a strong presence in the healthcare industry. Pharmscript is renowned for its innovative medication management solutions, which streamline pharmacy operations and enhance patient care. The company offers a range of core services, including customised medication packaging and comprehensive pharmacy consulting, setting it apart from competitors. With a commitment to quality and efficiency, Pharmscript has achieved significant milestones, including recognition for its exceptional service delivery in the long-term care sector. As a trusted partner for healthcare providers, Pharmscript continues to strengthen its market position through a focus on patient-centric solutions and operational excellence.
DitchCarbon Score
How does Pharmscript, L.L.C.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmscript, L.L.C.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmscript, L.L.C., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of UnitedHealth Group Incorporated, which influences its climate commitments and initiatives. While Pharmscript has not set its own reduction targets, it inherits sustainability goals and initiatives from its parent company, UnitedHealth Group. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down from UnitedHealth Group at a corporate family level. Pharmscript's climate strategy aligns with broader industry standards, focusing on reducing carbon footprints and enhancing sustainability practices. However, specific reduction targets or achievements have not been disclosed at this time. The company is expected to follow the climate commitments established by its parent organisation, contributing to a collective effort towards climate action within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Pharmscript, L.L.C.'s Industry?
How Carbon Intensive is Pharmscript, L.L.C.'s Location?
Pharmscript, L.L.C.'s Scope 3 Categories Breakdown
Pharmscript, L.L.C.'s Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Pharmscript, L.L.C.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmscript, L.L.C. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
